
Opinion|Videos|May 15, 2024
Safety Analysis and Interpreting Results from MAJIC-PV
Following a review of the safety analysis of MAJIC-PV, the panel discusses the main limitations and key takeaways from the study.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Daraxonrasib trial exceeds expectations after decades of disappointment in pancreatic cancer drug development
2
340B reform and drug shortages are among hospital pharmacy concerns, survey finds
3
Alyana Samai, M.P.H. | 2026 MHE Emerging Leaders in Healthcare
4
Dual-target ADC shows promising PFS signal in mCRPC | ASCO 2025
5

























